Table 1.
Montgomery | Shenzhen | Belarus | Total | |
---|---|---|---|---|
Patients | 138 | 662 | 304 | 1104 |
without TBC | 80 | 326 | 0 | 406 |
With TBC | 58 | 336 | 304 | 698 |
Male | 63 | 442 | 194 | 699 |
Female | 74 | 213 | 110 | 397 |
Other/Unknown | 1 | 7 | 0 | 8 |
Cross-validation subset | 27–28 | 132–133 | — | 220–221 |
The last row indicates the size of a subset used for the cross-validation study, which is about one-fifth of the total size of the dataset. It also represents the size of the validation and test sets.